GLOBUS MEDICAL, INC. (NYSE:GMED) Files An 8-K Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition.
preliminary unaudited sales results for the three months and year
ended December 31, 2016, and providing preliminary guidance for
certain financial measures for the 2017 fiscal year. A copy of
the press release is furnished as Exhibit 99.1 to this report.
information included in this Item 2.02, and the exhibits attached
hereto, shall be deemed to be furnished and shall not be deemed
to be filed with the Securities and Exchange Commission for
purposes of Section 18 of the Securities Exchange Act of 1934, as
amended.
|
Exhibit No.
|
Description
|
|
99.1
|
Press Release dated January 10, 2017
|
About GLOBUS MEDICAL, INC. (NYSE:GMED)
Globus Medical, Inc. is a medical device company. The Company is focused on developing products for patients with musculoskeletal disorders. It is focused on products to treat patients with spine disorders. Its products fall under categories, which include Innovative Fusion and Disruptive Technologies. The Innovative Fusion category products include fusion products to treat spinal disorders for the entire spine, and they can be used in various surgical approaches. The Disruptive Technologies category represents a shift in the treatment of spinal disorders by allowing for surgical procedures and the treatment of spinal disorders. The Company’s Disruptive Technology products include motion preservation offerings, such as SECURE-C and SECURE-CR; MONUMENT, an interbody implant for the reduction of a grade 1 spondylolisthesis; KINEX and SIGNIFY bone void fillers, and CONDUCT ceramic-collagen, and SHIELD and AFFIRM products that allow for the treatment of vertebral compression fractures. GLOBUS MEDICAL, INC. (NYSE:GMED) Recent Trading Information
GLOBUS MEDICAL, INC. (NYSE:GMED) closed its last trading session up +0.42 at 25.32 with 1,208,675 shares trading hands.